Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	43.46B +96.7%
Revenue (ttm)	6.93B +16.6%
Net Income	1.11B +11.7%
EPS	3.11 +10.0%
Shares Out	359.72M
PE Ratio	39.76
Forward PE	30.19
Dividend	1.30 (1.05%)
Ex-Dividend Date	Jun 26, 2025

Volume	5,666,072
Average Volume	9,663,250
Open	128.09
Previous Close	128.08
Day's Range	123.45 - 128.80
52-Week Range	79.04 - 131.29
Beta	0.16
RSI	58.54
Earnings Date	Aug 27, 2026

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in ke...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 10,617
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2025, SHE:002821's revenue was 6.67 billion, an increase of 14.91% compared to the previous year's 5.80 billion. Earnings were 1.13 billion, an increase of 19.35%.